Search / Trial NCT06613425

Clinical Study of Combined Platelet Transfusion

Launched by THE GENERAL HOSPITAL OF WESTERN THEATER COMMAND · Sep 23, 2024

Trial Information

Current as of December 21, 2024

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a new way to prepare and use platelets for patients with blood disorders that cause low platelet counts or problems with how platelets work. Platelet transfusions are crucial for treating these conditions, but sometimes it's challenging to find suitable platelets that match a patient's blood type. This study is looking at "combined platelets," which can be infused safely even when there are some mismatches in blood types. The goal is to make platelet transfusions safer and more effective for patients.

To be eligible for this trial, participants should be between 18 and 65 years old and receiving treatment at the research hospital, where they need platelet transfusion therapy. Individuals who have recently participated in other related clinical trials or do not need platelet transfusions are not eligible. Participants can expect to receive combined platelet transfusions over a six-month period and will be monitored to assess the effectiveness of this treatment. This trial aims to help improve outcomes for patients who rely on platelet transfusions.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Aged 18-65 years; 2. Disease treatment in the research hospital; 3. Applied for platelet transfusion therapy.
  • Exclusion Criteria:
  • 1. One month before the start of this study, he participated in other clinical trials of drugs and instruments related to platelet transfusion efficacy; 2. Without platelet transfusion indications; 3. Only received platelet transfusion in the outpatient department and left the hospital without efficacy evaluation after transfusion; 4. Gave up platelet transfusion therapy for any reason after enrollment; 5. Transferred or discharged from hospital for any reason before platelet transfusion after enrollment; 6. Did not receive combined platelet transfusion during the 6-month treatment period after enrollment

Trial Officials

zhang li

Principal Investigator

The General Hospital of Weastern Theater Command

About The General Hospital Of Western Theater Command

The General Hospital of Western Theater Command is a leading military medical institution dedicated to advancing healthcare through innovative research and clinical trials. With a commitment to enhancing patient care and medical practices, the hospital integrates cutting-edge technology and multidisciplinary expertise to conduct rigorous clinical studies. By focusing on the unique health needs of military personnel and the broader community, the General Hospital aims to contribute significantly to medical knowledge and improve treatment outcomes across various health conditions. Its strategic location and resources position it as a vital player in advancing military and civilian healthcare initiatives.

Locations

Chengdu, Sichuan, China

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0